Harvard Bioscience (HBIO) 5.31 $HBIO
Harvard Bioscience Schedules Fourth Quarter and Year-End 2014 Conference Call for February 26 at 11:00 AM ET
GlobeNewswire - Fri Feb 13, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its fourth quarter and year-end 2014 before market trading hours on Thursday, February 26, 2015. A conference call to discuss the company's fourth quarter and year-end 2014 and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 5.31 (-0.01)
Harvard Bioscience Up 11.6% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Tue Feb 10, 9:22AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 11.62% as of today's recent price of $5.24.
HBIO: 5.31 (-0.01)
Shares of HBIO Up 18.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 11:21AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 3 months, Harvard Bioscience has returned 18.76% as of today's recent price of $5.57.
HBIO: 5.31 (-0.01)
Harvard Bio buys German biomedical instrument maker
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 12:57PM CST
HBIO: 5.31 (-0.01)
Harvard Bioscience Acquires All Operations of HEKA Electronik
GlobeNewswire - Thu Jan 08, 9:36AM CST
Expected to Add $4 Million to $5 Million in Revenue in 2015
HBIO: 5.31 (-0.01)
Harvard Bioscience to Present at Inaugural Equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014
GlobeNewswire - Tue Dec 16, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014. Jeffrey Duchemin, President and Chief Executive Officer, and Robert Gagnon, Chief Financial Officer, will present at 2:50 pm ET.
HBIO: 5.31 (-0.01)
Affymetrix, Binding Site Group Ink Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 4:25PM CST
Provider of life science tools and molecular diagnostic products, Affymetrix Inc. (AFFX), recently announced that its eBioscience business has entered into a multi-year distribution agreement with The Binding Site Group Ltd.
HBIO: 5.31 (-0.01), BIO: 118.36 (+0.79), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)
Affymetrix Axiom Genotyping Platform Selected by Toshiba - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 5:10PM CST
The Axiom Genotyping Solution platform of Affymetrix (AFFX) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service.
HBIO: 5.31 (-0.01), BIO: 118.36 (+0.79), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)
I'm Selling Harvard Apparatus Regenerative Technology
Jim Royal, The Motley Fool - Motley Fool - Tue Nov 18, 8:27AM CST
It's time to sell Harvard Apparatus Regenerative Technology . My Special Situations portfolio acquired shares in the speculative research and development company before it was spun off from Harvard Bioscience last year. Why sell? In...
HBIO: 5.31 (-0.01), HART: 2.92 (+0.34)
Harvard Bioscience to Exhibit at Society for Neuroscience 2014 Annual Meeting in Washington, DC on November 16-19
GlobeNewswire - Thu Nov 13, 6:30AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, announced it will exhibit its life science equipment and instruments at the Society for Neuroscience 2014 Annual Meeting at the Walter E. Washington Convention Center in Washington, DC on November 16-19 in four separate booths.
HBIO: 5.31 (-0.01)
Harvard Bioscience elects Bertrand Loy to board
M2 - Tue Nov 11, 6:56AM CST
Life science solution company Harvard Bioscience (NasdaqGM:HBIO) reported on Monday the appointment of Bertrand Loy to its board of directors effective immediately.
HBIO: 5.31 (-0.01), ENTG: 13.50 (-0.15)
Harvard Bioscience Appoints Bertrand Loy to Board of Directors
GlobeNewswire - Mon Nov 10, 6:30AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has appointed Bertrand Loy to its Board of Directors, effective immediately.
HBIO: 5.31 (-0.01), ENTG: 13.50 (-0.15)
Harvard Bioscience's (HBIO) CEO Jeff Duchemin on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 01, 8:33PM CDT
HBIO: 5.31 (-0.01)
PerkinElmer (PKI) Posts In-Line Q3 Earnings, Revenue Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 10:40AM CDT
PerkinElmer Inc. (PKI) reported earnings of 57 cents per share in the third quarter of 2014, in line with the Zacks Consensus Estimate, but up 14% on a year-over-year basis.
HBIO: 5.31 (-0.01), ATEC: 1.34 (unch), NEWP: 20.29 (-0.01), PKI: 46.30 (-0.10)
The Company That Can Grow You A New Organ: A Promising Long-Term Investment
Daniel Kohlsdorf - Seeking Alpha - Thu Oct 30, 10:37AM CDT
About the company and its opportunities Harvard Apparatus Regenerative Technology (NASDAQ: HART ) makes the equipment used to create a new human trachea (breathing pipe) using the patient's own bone marrow cells. People who currently need a...
HBIO: 5.31 (-0.01), HART: 2.92 (+0.34)
Harvard Bioscience posts 3Q profit
Automated Insights - Thu Oct 30, 10:16AM CDT
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Thursday reported net income of $633,000 in its third quarter.
HBIO: 5.31 (-0.01)
Harvard Bioscience (HBIO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55AM CDT
HBIO: 5.31 (-0.01)
Harvard Bioscience EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:49AM CDT
HBIO: 5.31 (-0.01)
Harvard Bioscience Reports Third Quarter 2014 Results
GlobeNewswire - Thu Oct 30, 6:30AM CDT
Operational Improvements Produce Increases in Operating Income and Margins
HBIO: 5.31 (-0.01)
Harvard Bioscience Schedules Fourth Quarter and Year-End 2014 Conference Call for February 26 at 11:00 AM ET
GlobeNewswire - Fri Feb 13, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will announce results for its fourth quarter and year-end 2014 before market trading hours on Thursday, February 26, 2015. A conference call to discuss the company's fourth quarter and year-end 2014 and its operations is scheduled for that same date at 11:00 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, including operations, plans and outlook.
HBIO: 5.31 (-0.01)
Harvard Bioscience Up 11.6% Since SmarTrend Uptrend Call (HBIO)
Comtex SmarTrend(R) - Tue Feb 10, 9:22AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 4 months, Harvard Bioscience has returned 11.62% as of today's recent price of $5.24.
HBIO: 5.31 (-0.01)
Shares of HBIO Up 18.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 11:21AM CST
SmarTrend identified an Uptrend for Harvard Bioscience (NASDAQ:HBIO) on October 21st, 2014 at $4.69. In approximately 3 months, Harvard Bioscience has returned 18.76% as of today's recent price of $5.57.
HBIO: 5.31 (-0.01)
Harvard Bio buys German biomedical instrument maker
Seeking Alpha - at Seeking Alpha - Thu Jan 08, 12:57PM CST
HBIO: 5.31 (-0.01)
Harvard Bioscience Acquires All Operations of HEKA Electronik
GlobeNewswire - Thu Jan 08, 9:36AM CST
Expected to Add $4 Million to $5 Million in Revenue in 2015
HBIO: 5.31 (-0.01)
Harvard Bioscience to Present at Inaugural Equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014
GlobeNewswire - Tue Dec 16, 6:00AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, will present at the inaugural equities.com Small-Cap Stars Conference at the NASDAQ MarketSite in New York City on December 18, 2014. Jeffrey Duchemin, President and Chief Executive Officer, and Robert Gagnon, Chief Financial Officer, will present at 2:50 pm ET.
HBIO: 5.31 (-0.01)
Affymetrix, Binding Site Group Ink Distribution Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 4:25PM CST
Provider of life science tools and molecular diagnostic products, Affymetrix Inc. (AFFX), recently announced that its eBioscience business has entered into a multi-year distribution agreement with The Binding Site Group Ltd.
HBIO: 5.31 (-0.01), BIO: 118.36 (+0.79), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)
Affymetrix Axiom Genotyping Platform Selected by Toshiba - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 5:10PM CST
The Axiom Genotyping Solution platform of Affymetrix (AFFX) has been selected by Toshiba's Healthcare Company as the platform for its newly launched genotyping service.
HBIO: 5.31 (-0.01), BIO: 118.36 (+0.79), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)
I'm Selling Harvard Apparatus Regenerative Technology
Jim Royal, The Motley Fool - Motley Fool - Tue Nov 18, 8:27AM CST
It's time to sell Harvard Apparatus Regenerative Technology . My Special Situations portfolio acquired shares in the speculative research and development company before it was spun off from Harvard Bioscience last year. Why sell? In...
HBIO: 5.31 (-0.01), HART: 2.92 (+0.34)
Harvard Bioscience to Exhibit at Society for Neuroscience 2014 Annual Meeting in Washington, DC on November 16-19
GlobeNewswire - Thu Nov 13, 6:30AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of equipment, instruments and solutions to advance life science, announced it will exhibit its life science equipment and instruments at the Society for Neuroscience 2014 Annual Meeting at the Walter E. Washington Convention Center in Washington, DC on November 16-19 in four separate booths.
HBIO: 5.31 (-0.01)
Harvard Bioscience elects Bertrand Loy to board
M2 - Tue Nov 11, 6:56AM CST
Life science solution company Harvard Bioscience (NasdaqGM:HBIO) reported on Monday the appointment of Bertrand Loy to its board of directors effective immediately.
HBIO: 5.31 (-0.01), ENTG: 13.50 (-0.15)
Harvard Bioscience Appoints Bertrand Loy to Board of Directors
GlobeNewswire - Mon Nov 10, 6:30AM CST
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has appointed Bertrand Loy to its Board of Directors, effective immediately.
HBIO: 5.31 (-0.01), ENTG: 13.50 (-0.15)
Harvard Bioscience's (HBIO) CEO Jeff Duchemin on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 01, 8:33PM CDT
HBIO: 5.31 (-0.01)
PerkinElmer (PKI) Posts In-Line Q3 Earnings, Revenue Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 10:40AM CDT
PerkinElmer Inc. (PKI) reported earnings of 57 cents per share in the third quarter of 2014, in line with the Zacks Consensus Estimate, but up 14% on a year-over-year basis.
HBIO: 5.31 (-0.01), ATEC: 1.34 (unch), NEWP: 20.29 (-0.01), PKI: 46.30 (-0.10)
The Company That Can Grow You A New Organ: A Promising Long-Term Investment
Daniel Kohlsdorf - Seeking Alpha - Thu Oct 30, 10:37AM CDT
About the company and its opportunities Harvard Apparatus Regenerative Technology (NASDAQ: HART ) makes the equipment used to create a new human trachea (breathing pipe) using the patient's own bone marrow cells. People who currently need a...
HBIO: 5.31 (-0.01), HART: 2.92 (+0.34)
Harvard Bioscience posts 3Q profit
Automated Insights - Thu Oct 30, 10:16AM CDT
HOLLISTON, Mass. (AP) _ Harvard Bioscience Inc. (HBIO) on Thursday reported net income of $633,000 in its third quarter.
HBIO: 5.31 (-0.01)
Harvard Bioscience (HBIO) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:55AM CDT
HBIO: 5.31 (-0.01)
Harvard Bioscience EPS and revenue in-line
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:49AM CDT
HBIO: 5.31 (-0.01)
Harvard Bioscience Reports Third Quarter 2014 Results
GlobeNewswire - Thu Oct 30, 6:30AM CDT
Operational Improvements Produce Increases in Operating Income and Margins
HBIO: 5.31 (-0.01)
